OmniAb (OABI) Change in Accured Expenses (2021 - 2026)

OmniAb's (OABI) quarterly Change in Accured Expenses came in at -$2.5 million in Q1 2026, up 15.03% year-on-year from -$2.2 million in Q1 2025, and down 300.16% on a QoQ basis from $1.3 million in Q4 2025.

OmniAb (OABI) Change in Accured Expenses (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Change in Accured Expenses data on file, last reported at -$2.5 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 15.03% year-over-year to -$2.5 million in Q1 2026; TTM through Mar 2026 was $215000.0, a 111.0% increase from a year earlier, with the FY2025 full-year figure at -$231000.0, up 90.41% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$2.5 million, down from $1.3 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for OABI reached as high as $14.6 million in Q4 2022 and fell as low as -$3.4 million in Q1 2024.
  • Historically, Change in Accured Expenses has averaged $636764.7 across 5 years, with a median of $280000.0 in 2025.
  • Across the five-year window, Change in Accured Expenses soared 2257.45% in 2023 and slumped 114.8% in 2024, its largest moves.
  • Year by year, Change in Accured Expenses stood at $14.6 million in 2022, then tumbled by 103.59% to -$526000.0 in 2023, then surged by 247.53% to $776000.0 in 2024, then jumped by 62.37% to $1.3 million in 2025, then plunged by 300.16% to -$2.5 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$2.5 million in Q1 2026, $1.3 million in Q4 2025, and $280000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 1.13 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 931,000.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -16.82 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -16.74 Mn
10 OmniAb 260.98 Mn 211.91 Mn 14.41 Mn -2.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.52 Mn
Mar 31, 2026 -2.52 Mn
Dec 31, 2025 1.26 Mn
Dec 31, 2025 1.26 Mn
Sep 30, 2025 280,000.00
Sep 30, 2025 280,000.00
Jun 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 -2.97 Mn
Mar 31, 2025 -2.97 Mn
Dec 31, 2024 776,000.00
Dec 31, 2024 776,000.00
Sep 30, 2024 402,000.00
Sep 30, 2024 402,000.00
Jun 30, 2024 -164,000.00
Jun 30, 2024 -164,000.00
Mar 31, 2024 -3.42 Mn
Mar 31, 2024 -3.42 Mn
Dec 31, 2023 -526,000.00
Dec 31, 2023 -526,000.00